Altogether, these results suggest that loss of ST6GAL1 function, through knockdown or blocking its proteolysis, augments IL-6 secretion in HBECs and is associated with poor clinical outcomes in COPD. This evidence concerns the gene ST6GAL1 and chronic obstructive pulmonary disease.